ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,572.85
0.10%
Dow Jones
39,344.79
-0.08%
US Dollar vs MXN
18.0424
0.30%
Brent Oil
85.115
-0.35%
Bitcoin
57,453.49
1.32%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
09/07/202405:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:DTDynatrace Inc
09/07/202405:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APLDApplied Digital Corporation
09/07/202405:33Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNYSE:DTDynatrace Inc
09/07/202405:31Business WireAir Lease Corporation Activity Update for the Second Quarter of 2024NYSE:ALAir Lease Corporation
09/07/202405:31GlobeNewswire Inc.Falco Resources Invites Citizens to an Immersive Workshop on the Acoustic and Vibratory Climate Ahead of the Imminent Announcement of a BAPETSXV:FPCFalco Resources Ltd
09/07/202405:31GlobeNewswire Inc.60 Degrees Pharma Announces IRB Approval of Clinical Study of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients with Persistent Babesia microti Despite Prior TreatmentNASDAQ:SXTP60 Degrees Pharmaceuticals Inc
09/07/202405:30GlobeNewswire Inc.Probe Gold Expands Gold Zones at its Croinor Gold Property, Val-d’Or, QuebecTSX:PRBProbe Gold Inc
09/07/202405:30Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNYSE:SEDASDCL EDGE Acquisition Corporation
09/07/202405:30GlobeNewswire Inc.Azimut Resumes Drilling at Elmer and Discovers a Copper-Gold Showing by ProspectingTSXV:AZMAzimut Exploration Inc
09/07/202405:30GlobeNewswire Inc.Hut 8 Executes Definitive Agreements for Site in West Texas with 205 MW of Immediately Available Power CapacityTSX:HUTHut 8 Corp
09/07/202405:30GlobeNewswire Inc.Cheer Holding Attends SME Innovation and Development Forum of the Global Digital Economy Conference 2024NASDAQ:CHRCheer Holding Inc
09/07/202405:30GlobeNewswire Inc.Sotherly Hotels Inc. Announces Refinancing and Relaunch Plans for Jacksonville, FL HotelNASDAQ:SOHOSotherly Hotels Inc
09/07/202405:30Business WireCanoe Intelligence Raises $36 Million Series C Funding Led by Goldman Sachs to Further Market Expansion
09/07/202405:30Business WireUBS Hires Private Wealth Management Team in Westlake Village, CANYSE:UBSUBS Group AG
09/07/202405:30GlobeNewswire Inc.FTAI Infrastructure Inc. Announces Timing of Second Quarter 2024 Earnings and Conference CallNASDAQ:FIPFTAI Infrastructure Inc
09/07/202405:30Business WireRadian to Webcast Second Quarter Conference CallNYSE:RDNRadian Group Inc
09/07/202405:30Business WireITT to Release Second Quarter 2024 Results on Thursday, Aug. 1NYSE:ITTITT Inc
09/07/202405:30Business WireNew Nextdoor Feature Connects Neighbors Nationwide with Localized Power Outage Alerts Alongside Anticipated Summer HeatNYSE:KINDNextdoor Holdings Inc
09/07/202405:30PR Newswire (Canada)NEW GOLD PROVIDES NOTICE OF RELEASE OF SECOND QUARTER 2024 RESULTS AND CONFERENCE CALLAMEX:NGDNew Gold Inc
09/07/202405:30PR Newswire (US)Immunic Appoints Jason Tardio as Chief Operating Officer and PresidentNASDAQ:IMUXImmunic Inc
09/07/202405:30PR Newswire (US)GoldMining Confirms Additional Mineralization at the São Jorge Project, Brazil, Including 19 Metres Grading 1.24 g/t GoldTSX:GOLDGoldMining Inc
09/07/202405:30PR Newswire (US)Buchanan & Edwards awarded FBI Information Technology Supplies and Support Services 2nd Generation (ITSSS-2) Blanket Purchase Agreement
09/07/202405:30PR Newswire (US)JOHNSTON & MURPHY REVAMPS TWO MALL LOCATIONSNYSE:GCOGenesco Inc
09/07/202405:30PR Newswire (US)State of Colorado selects CGI for payroll system modernization, empowering 33,000 state employees with enhanced efficiencyNYSE:GIBCGI Inc
09/07/202405:30PR Newswire (US)VIAVI VALOR and Telecom Infra Project (TIP) Announce Strategic Collaboration to Advance Open RAN Testing CapabilitiesNASDAQ:VIAVViavi Solutions Inc
09/07/202405:30PR Newswire (US)Cast Elastomer Market Set to Grow at 5% CAGR, reaching $2.49 Billion by 2034, States Fact.MR
09/07/202405:30PR Newswire (Canada)L'État du Colorado choisit CGI pour la modernisation de son système de paie, permettant d'en améliorer l'efficacité pour ses 33 000 employésTSX:GIB.ACGI Inc
09/07/202405:29PR Newswire (US)MOON VALLEY NURSERIES EXPANDS NURSERY OPERATIONS TO GEORGIA
09/07/202405:28Business WirePershing Square USA, Ltd. Announces Launch of IPO Roadshow
09/07/202405:25PR Newswire (US)MoonFox Analysis | Dungeon & Fighter Generates $137 million in first week - Can the youth touch help regain the glory of the original PC game?NASDAQ:JGAurora Mobile Ltd

Su Consulta Reciente

NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLF
Financial Select Sector
NYSE
AXP
American Express
AMEX
SPY
SPDR S&P 500
COIN
SOLUSD
Solana
CCOM
SILVER
SILVER
NASDAQ
AMZN
Amazon.com
NYSE
KO
Coca Cola
AMEX
XLE
Energy Select Sector SPDR
NYSE
VZ
Verizon Communications
CCOM
US500
US 500
USOTC
RHHBY
Roche (QX)
FX
EURMXN
Euro vs MXN
FX
USDMXN
US Dollar vs MXN
CCOM
US30
US 30
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados